Skip to Content
Merck
All Photos(1)

Key Documents

Safety Information

G2901

Sigma-Aldrich

Gly-Pro p-nitroanilide p-toluenesulfonate salt

chromogenic, ~99% (TLC), powder

Synonym(s):

GPDA, Gly-Pro-pNA TosOH

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C13H16N4O4 · C7H8O3S
CAS Number:
Molecular Weight:
464.49
MDL number:
UNSPSC Code:
12352204
PubChem Substance ID:
NACRES:
NA.32

product name

Gly-Pro p-nitroanilide p-toluenesulfonate salt, ~99% (TLC)

Assay

~99% (TLC)

Quality Level

form

powder

solubility

1 M HCl: 50 mg/mL

storage temp.

−20°C

SMILES string

Cc1ccc(cc1)S(O)(=O)=O.NCC(=O)N2CCC[C@H]2C(=O)Nc3ccc(cc3)[N+]([O-])=O

InChI

1S/C13H16N4O4.C7H8O3S/c14-8-12(18)16-7-1-2-11(16)13(19)15-9-3-5-10(6-4-9)17(20)21;1-6-2-4-7(5-3-6)11(8,9)10/h3-6,11H,1-2,7-8,14H2,(H,15,19);2-5H,1H3,(H,8,9,10)/t11-;/m0./s1

InChI key

XHLUWCXVWCBOPP-MERQFXBCSA-N

Looking for similar products? Visit Product Comparison Guide

Application

Gly-Pro p-nitroanilide p-toluenesulfonate salt has been used as a substrate to assay dipeptidyl peptidase IV (DPPIV) activity in serum, and brush border homogenates.

Substrates

Substrate for Dipeptidyl Peptidase IV.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

G2901-VAR:
G2901-25MG:
G2901-100MG:
G2901-BULK:
G2901-250MG:


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Delphine Ley et al.
Scientific reports, 9(1), 18111-18111 (2019-12-04)
The first thousand days of life are a critical time of development in humans during which the risk profile for diseases in later life can be modified. Nevertheless, long-term consequences of early environment on susceptibility to intestinal diseases have not
Ivana Z Matić et al.
Leukemia & lymphoma, 54(12), 2701-2706 (2013-03-09)
The aim of this research was to determine the serum dipeptidyl peptidase IV (DPPIV) activity as well as the percentages of CD26 + lymphocytes and CD26 + overall white blood cells in patients with hematological malignancies: non-Hodgkin lymphoma (NHL), Hodgkin
Delphine Ley et al.
Scientific reports, 9(1), 18111-18111 (2019-12-04)
The first thousand days of life are a critical time of development in humans during which the risk profile for diseases in later life can be modified. Nevertheless, long-term consequences of early environment on susceptibility to intestinal diseases have not
Anna Iwaniak et al.
International journal of molecular sciences, 22(6) (2021-04-04)
In silico and in vitro methods were used to analyze ACE- and DPP-IV-inhibiting potential of Gouda cheese with a modified content of β-casein. Firstly, the BIOPEP-UWM database was used to predict the presence of ACE and DPP-IV inhibitors in casein

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service